Publications by authors named "Comfort Boateng"

Claim this Profile
N
Novel Dopamine 4 Receptor Ligands Differentially Ameliorate ADHD-like Behaviors in Spontaneously Hypertensive Rats.
Ike C de la Peña, Samantha Andino, Ashley Amis, Mohammad A Alkhatib, Tian Li, Comfort A Boateng

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia.
Alessandro Bonifazi, Michael Ellenberger, Zachary J Farino, Despoina Aslanoglou, Rana Rais, Comfort A Boateng

Diabetes· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of novel tools for dissection of central versus peripheral dopamine D-like receptor signaling in dysglycemia.
Alessandro Bonifazi, Michael Ellenberger, Zachary J Farino, Despoina Aslanoglou, Rana Rais, Comfort A Boateng

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.
Comfort A Boateng, Ashley N Nilson, Rebekah Placide, Mimi L Pham, Franziska M Jakobs

J Med Chem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and pharmacological role of the dopamine D receptor and its polymorphic variants.
Sergi Ferré, Annabelle M Belcher, Jordi Bonaventura, César Quiroz, Marta Sánchez-Soto, Comfort A Boateng

Front Endocrinol (Lausanne)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections of six neuroscientists: The influences of training at minority serving institutions.
Wendy Grillo, Comfort A Boateng, Lillian J Brady, Monica M Gaudier-Diaz, Kerry-Ann Mitchell

J Neurosci Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D/D Receptor Bitopic Ligands.
Anver Basha Shaik, Comfort A Boateng, Francisco O Battiti, Alessandro Bonifazi, Jianjing Cao

J Med Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Marta Sanchez-Soto, Ravi Kumar Verma, Blair K A Willette, Elizabeth C Gonye, Annah M Moore, Comfort A Boateng

Sci Signal· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine D Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy.
Thomas M Keck, R Benjamin Free, Marilyn M Day, Sonvia L Brown, Michele S Maddaluna, Comfort A Boateng

J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.
Zhi-Bing You, Jun-Tao Gao, Guo-Hua Bi, Yi He, Comfort Boateng

Neuropharmacology· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D Receptor.
Mayako Michino, Comfort A Boateng, Prashant Donthamsetti, Hideaki Yano, Oluyomi M Bakare

J Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.
Comfort A Boateng, Oluyomi M Bakare, Jia Zhan, Ashwini K Banala, Caitlin Burzynski

J Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents.
Sidney Bolden, Xue Y Zhu, Jagan R Etukala, Comfort Boateng, Tryphon Mazu

Eur J Med Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CoMFA studies and in vitro evaluation of some 3-substituted benzylthio quinolinium salts as anticryptococcal agents.
Sidney Bolden, Comfort A Boateng, Xue Y Zhu, Jagan R Etukala, Suresh K Eyunni

Bioorg Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of 3-(phenylthio)quinolinium compounds against opportunistic fungal pathogens.
Comfort A Boateng, Xue Y Zhu, Melissa R Jacob, Shabana I Khan, Larry A Walker

Eur J Med Chem· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.
Comfort A Boateng, Suresh V K Eyunni, Xue Y Zhu, Jagan R Etukala, Barbara A Bricker

Bioorg Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis